Stay updated with breaking news from Biodelivery Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We recently compiled the list of the 10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts. In this article, we are going to take a look at where Collegium Pharmaceutical, Inc.
JUPITER, Fla. & DURHAM - Ligand Pharmaceuticals today announced the launch of Pelthos Therapeutics , a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to...
Pharmaceutical executive Scott Plesha named CEO Lead product ZELSUVMI expected to be commercially available in late 2024 ...
Ligand Pharmaceuticals (LGND) announced the launch of Pelthos Therapeutics, a biopharmaceutical company. Pelthos is a wholly owned subsidiary of Ligand. Pelthos is committed to commercializing therapeutic products to help patients impacted by diseases with limited treatment options.
(RTTNews) - Ligand Pharmaceuticals (LGND) announced the launch of Pelthos Therapeutics, a biopharmaceutical company. Pelthos is a wholly owned sub...